Wordt geladen...
Unilateral Macular Choroidal Neovascularization; a Rare Manifestation in Chronic Myelogenous Leukemia
PURPOSE: To report a case of chronic myelogenous leukemia (CML) treatment with imatinib mesylate in the remission phase who developed unilateral macular choroidal neovascularization (CNV). METHODS: A 45-year-old male marketer with a 5-year history of CML treated with imatinib mesylate presented with...
Bewaard in:
| Gepubliceerd in: | J Curr Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer - Medknow
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265268/ https://ncbi.nlm.nih.gov/pubmed/32510022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.09.003 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|